Results for tag: "Tau Inhibitor"

Tau Inhibitors are a class of drugs used to treat Alzheimer's Disease. They work by targeting the tau protein, which is believed to be a major contributor to the development of the disease. Tau Inhibitors are designed to reduce the amount of tau protein in the brain, which can help slow the progression of Alzheimer's Disease. These drugs are typically used in combination with other treatments, such as cholinesterase inhibitors, to maximize their effectiveness. Tau Inhibitors are still in the early stages of development, and there are currently no approved drugs on the market. However, several pharmaceutical companies are actively researching and developing Tau Inhibitors, and clinical trials are underway. Some of the companies in the Tau Inhibitor market include Biogen, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more